Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Michael Amini Transfusion Medicine Center, City of Hope, Duarte, California, United States of America.
PLoS Pathog. 2024 Mar 11;20(3):e1012079. doi: 10.1371/journal.ppat.1012079. eCollection 2024 Mar.
Macrophages can undergo M1-like proinflammatory polarization with low oxidative phosphorylation (OXPHOS) and high glycolytic activities or M2-like anti-inflammatory polarization with the opposite metabolic activities. Here we show that M1-like macrophages induced by hepatitis B virus (HBV) display high OXPHOS and low glycolytic activities. This atypical metabolism induced by HBV attenuates the antiviral response of M1-like macrophages and is mediated by HBV e antigen (HBeAg), which induces death receptor 5 (DR5) via toll-like receptor 4 (TLR4) to induce death-associated protein 3 (DAP3). DAP3 then induces the expression of mitochondrial genes to promote OXPHOS. HBeAg also enhances the expression of glutaminases and increases the level of glutamate, which is converted to α-ketoglutarate, an important metabolic intermediate of the tricarboxylic acid cycle, to promote OXPHOS. The induction of DR5 by HBeAg leads to apoptosis of M1-like and M2-like macrophages, although HBeAg also induces pyroptosis of the former. These findings reveal novel activities of HBeAg, which can reprogram mitochondrial metabolism and trigger different programmed cell death responses of macrophages depending on their phenotypes to promote HBV persistence.
巨噬细胞可以表现出 M1 样促炎极化,具有低氧化磷酸化(OXPHOS)和高糖酵解活性,或 M2 样抗炎极化,具有相反的代谢活性。在这里,我们表明乙型肝炎病毒(HBV)诱导的 M1 样巨噬细胞显示出高 OXPHOS 和低糖酵解活性。HBV 诱导的这种非典型代谢减弱了 M1 样巨噬细胞的抗病毒反应,由 HBV e 抗原(HBeAg)介导,HBeAg 通过 Toll 样受体 4(TLR4)诱导死亡受体 5(DR5),从而诱导死亡相关蛋白 3(DAP3)。DAP3 然后诱导线粒体基因的表达以促进 OXPHOS。HBeAg 还增强了谷氨酰胺酶的表达并增加了谷氨酸的水平,谷氨酸转化为α-酮戊二酸,三羧酸循环的重要代谢中间产物,以促进 OXPHOS。HBeAg 诱导 DR5 的表达导致 M1 样和 M2 样巨噬细胞凋亡,尽管 HBeAg 也诱导前者发生细胞焦亡。这些发现揭示了 HBeAg 的新功能,它可以重新编程线粒体代谢,并根据其表型触发巨噬细胞的不同程序性细胞死亡反应,以促进 HBV 持续存在。